ArticleDigestive diseases and sciences2025

Olaparib Combined with Anti-PD1 Enhances Immunotherapy of Gastric Cancer Via NF-κB/c-Myc/PD-L1 Signaling.

Wubin Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.